Clinical Trial Update: Apixaban Versus Dual-antiplatelet Therapy (Clopidogrel and Aspirin) in Acute Non-disabling Cerebrovascular Events [Phase 2, Phase 3]

View source ↗

Summary

A clinical trial compares apixaban with dual antiplatelet therapy (clopidogrel plus aspirin) in patients with acute non-disabling cerebrovascular events (ischem…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke
• Transient Ischemic Attack

Drugs mentioned

• Apixaban (apixaban)
• Aspirin (Aspirin)
• CLOPIDOGREL (CLOPIDOGREL)

Snippet

Sponsor: Xijing Hospital | Conditions: Ischemic Stroke, TIA | Phase 2, Phase 3 | Status: UNKNOWN